Dr Reddy's Laboratories (RDY) Stock Statistics & Valuation Metrics

Dr Reddy's Laboratories has a market cap or net worth of $10.06B. The enterprise value is $12.00K.

Dr Reddy's Laboratories has 834,636,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Dr Reddy's Laboratories’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.10%.

The current PE Ratio of Dr Reddy's Laboratories is 28.9. Dr Reddy's Laboratories’s PEG ratio is -1.17.

In the last 12 months, Dr Reddy's Laboratories had revenue of 353.47B and earned 45.09B in profits. Earnings per share was 53.92.

In the last 12 months, operating cash flow was 40.99B and capital expenditures -25.85B, giving a free cash flow of 15.15B billion.

Dr Reddy's Laboratories pays an annual dividend of $0.083, resulting in a dividend yield of 0.7%

Dr Reddy's Laboratories upcoming earnings date is Oct 23, 2026, Before Open (Confirmed).

Dr Reddy's Laboratories as a current ratio of 1.80, with Debt / Equity ratio of 18.77%

In the past 12 months, Dr Reddy's Laboratories has paid 13.00B in taxes.

Dr Reddy's Laboratories EV to EBITDA ratio is 13.66, with an EV/FCF ratio of 35.45.

Dr Reddy's Laboratories has $81.43B in cash and marketable securities with $71.95B in debt, giving a net cash position of $9.47B billion.

Gross margin is 50.18%, with operating margin of 13.83%, and net profit margin of 12.76%.

The average price target for Dr Reddy's Laboratories is $16.18, which is 11.43% higher than the current price. The consensus rating is Moderate Buy